Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: AACC, Premaitha Health, Lungevity Foundation, and More

NEW YORK (360Dx) – The American Association of Clinical Chemistry (AACC) announced this week the launch of the AACC Learning Lab developed through a collaboration with the NEJM Group — the publisher of the New England Journal of Medicine — and Area9 Learning, an adaptive learning technology firm. AACC Learning Lab is designed to help laboratory medicine experts expand their knowledge and enhance their ability to find answers to challenging patient health problems.

The material provided by AACC Learning Lab is divided into five program areas: clinical chemistry, hematology and coagulation, transfusion medicine, microbiology, and molecular diagnostics. Much of the material used for the clinical chemistry and molecular diagnostics courses is primarily derived from research and papers published in AACC’s Clinical Chemistry journal.

Premaitha Health said this week that it has added a number of new customers for its CE-marked noninvasive prenatal screening system through its distribution network in Southern Europe.

Premaitha said that in southern Italy, for example, its distributor won a public hospital tender to implement the first public noninvasive prenatal testing program. The hospital is expected to be ready to process routine samples using Premaitha’s Iona test in early Q2 2017.

Lungevity Foundation in collaboration with Stand Up To Cancer (SU2C) and the American Lung Association announced this week that the American Association for Cancer Research, SU2C's scientific partner, has issued a Call for Ideas for research proposals that focus on lung cancer early detection and interception. The combined team said it has up to $7 million in funding support.

Streck announced this week that its A1c-Cellular hemoglobin A1c (HbA1c) control with intact red blood cells is now assayed for the Beckman Coulter AU Series of instruments. The control tests the complete HbA1c procedure, including lysing of red blood cells — a step omitted with other controls, the firm said. A1c-Cellular is available in “two clinically significant levels.” It’s appropriate for immunoassay and ionic exchange HPLC methodologies, and can be assayed for popular chemistry instruments, Streck added.

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the 360Dx site.